Overview of Dr. Shapira Dr. Ilan Shapira is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. He received his medical degree from The Hebrew University of Jerusalem Hadassah Medical School and has been in practice 26 years. Dr. Shapira accepts several types of health insurance, listed below. He is one of 125 doctors at Mount Sinai Beth Israel and one of 90 doctors at Mount Sinai Morningside who specialize in Oncology. He has more than 20 publications and over 100 citings.
Education & Training Icahn School of Medicine at Mount Sinai (Beth Israel) Fellowship, Hematology and Medical Oncology, 1994 - 1997
Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital Residency, Internal Medicine, 1992 - 1994
Loyola University Medical Center Internship, Internal Medicine, 1991 - 1992
The Hebrew University of Jerusalem Hadassah Medical School Class of 1991
Certifications & Licensure Publications & Presentations PubMed
Unexpected pancytopenia: Dasatinib induced aplastic anemia in chronic myeloid leukemia.
Jonathan Feld, Amir Steinberg, Siraj M. El Jamal, Ilan Shapira> ;Journal of Oncology Pharmacy Practice. 2021 Jun 21 Paroxysmal Cold Hemoglobinuria in an Adult with Respiratory Syncytial Virus.
Ryan Leibrandt, Kenneth Angelino, Monique Vizel-Schwartz, Ilan Shapira> ;Case Reports in Hematology. 2018 Nov 13 Breast Implant-Associated Anaplastic Large Cell Lymphoma: Case Report and Review of the Literature.
Eva Berlin, Kunwar Singh, Christopher Mills, Ilan Shapira, Richard L. Bakst, Manjeet Chadha> ;Case Reports in Hematology. 2018 Jan 21 Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Ph...
Alexey V. Danilov, Hongli Li, Oliver W. Press, Ilan Shapira, Lode J. Swinnen, Ariela Noy, Erin Reid, Sonali M. Smith, Jonathan W. Friedberg> ;Leukemia & Lymphoma. 2017 Feb 1 Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.
Rahul R. Parikh, Bruce K. Moskowitz, Elizabeth Maher, David Della Rocca, Robert C. Della Rocca, Bruce Culliney, Ilan Shapira, Michael L. Grossbard, Louis B. Harrison, ...> ;Leukemia & Lymphoma. 2015 Jan 28 Ventriculitis Caused by Primary T-Cell CNS Lymphoma in an Immunocompetent Patient
Masayuki Nigo, Stacie L. Richardson, Efat Azizi, Jean-Marc Cohen, Ilan Shapira> ;Journal of Clinical Oncology. 2016 Sep 27 A Phase 2 Study of Oxaliplatin Combined With Continuous Infusion Topotecan for Patients With Previously Treated Ovarian Cancer
Stacey Stein, Amy Tiersten, H. Hochster, Stephanie V. Blank, Bhavana Pothuri, John P. Curtin, Ilan Shapira, Benjamin Levinson, Percy Ivy, Benson Joseph, Achuta Kumar G...> ;International Journal of Gynecological Cancer. 2013 Nov 1 Hepatosplenic γδ T-cell lymphoma: an overview.
Koppany Visnyei, Michael L. Grossbard, Ilan Shapira> ;Clinical Lymphoma, Myeloma & Leukemia. 2013 Aug 1 Clinical and cytogenetic characteristics of myelodysplastic syndrome in patients with HIV infection.
Koichi Takahashi, Mariko Yabe, Ilan Shapira, Sherry Pierce, Guillermo Garcia-Manero, Mala Varma> ;Leukemia Research. 2012 Nov 1 Does maternal or paternal inheritance of BRCA mutation affect the age of cancer diagnosis?
Shapira I, Gralla RJ, Akerman M, Weiselberg LR, John VS, Raftopoulos H, Vinciguerra V, Lovecchio JL, Menzin A, Cohen S> ;J. Clin. Oncol.. 2011-05-20 Documenting the complete resolution rates of venous thromboemboli (VTE) with the factor Xa inhibitor fondaparinux sodium (FS) in patients with cancer.
Budman DR, Barginear MF, Gralla RJ, Bradley TP, Shapira I, Nier-Shoulson NJ, Greben CR, Akerman M, Lesser M> ;J. Clin. Oncol.. 2011-05-20 Is there an advantage to adding inferior vena cava filter (IVCF) placement to anticoagulation with fondaparinux in patients with cancer and venous thromboemboli (VTE):...
Barginear MF, Gralla RJ, Akerman M, Lesser M, Bradley TP, Shapira I, Nier-Shoulson NJ, Greben CR, Budman DR> ;J. Clin. Oncol.. 2011-05-20 Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin.
Siddharth Verma, Shumei Kato, Ronald Blum, Ilan Shapira, Patricia Friedmann, Mala Varma> ;American Journal of Hematology. 2010 Aug 1 Supraclavicular extraskeletal myxoid chondrosarcoma presenting with a sensorimotor polyneuropathy associated with anti-Hu antibodies.
Andres Deik, Efat Azizi, Ilan Shapira, Irene R Boniece> ;Oncology. 2009 Jul 1 Oxaliplatin plus continuous infusion topotecan: First stage of an ongoing phase II study for recurrent ovarian cancer: A New York Cancer Consortium study (#N01-CM62204).
LaNatra N, Hochster H, Muggia F, Blank SV, Curtin J, Fishman D, Shapira IE, Goldberg GL, Parise S, Tiersten A> ;J. Clin. Oncol.. 2009-05-20 The impact of randomized trial results and altered regulatory policies on ESA use, transfusions, and thrombosis: A longitudinal analysis over a 3-year period of resour...
Shapira I, Raftopoulos H, Gralla RJ, Pelc K, Gleason K> ;J. Clin. Oncol.. 2009-05-20 Resolution of venous thrombo-emboli (VTE) with a factor Xa inhibitor: Initial safety and efficacy results of a randomized, phase III trial of anticoagulation plus infe...
Barginear MF, Budman DR, Gralla RJ, Shapira I, Bradley TP, Akerman M, Greben C, Strakhan M, Chandok A, Lesser M> ;J. Clin. Oncol.. 2008-05-20 Implications of applied research for prognosis and therapy of breast cancer.
Barginear MF, Bradley T, Shapira I, Budman DR> ;Crit. Rev. Oncol. Hematol.. 2008-03-01 Treatment of newly diagnosed, inner-city multiple myeloma patients with low-dose thalidomide and dexamethasone and zoledronate.
Klueppelberg UH, Kahn DM, Braunstein M, Smith EL, Shapira I, Batuman O> ;J. Clin. Oncol.. 2006-06-20 Anticoagulation vs. vena caval filters in cancer patients with venous thromboembolism: Improved survival with anticoagulation.
Barginear MF, Lesser ML, Strakhan M, Khetarpal P, Bradley T, Budman DR, Shapira I> ;J. Clin. Oncol.. 2006-06-20 CHOP chemotherapy is better than non-doxorubicin based therapy in patients with HTLV-1 adult T-cell leukemia-lymphoma (ATLL).
Shapira I, Feldman J, Solomon W> ;J. Clin. Oncol.. 2005-06-01 Long-term treatment of newly-diagnosed multiple myeloma with low-dose thalidomide, dexamethasone and zoledronate (TDZ).
Klueppelberg U, Shapira I, Chen L, Aloba MC, Smith E, Palanisamy N, Schmidt J, Moezi M, Batuman O> ;J. Clin. Oncol.. 2005-06-01 Complications of Therapy in Cancer Patients CASE 2. Scrotal Ulceration During All-Trans-Retinoic Acid Therapy for Acute Promyelocytic Leukemia
Scott Gettinger, Ilan Shapira, Noah Scheinfeld, Michael L. Grossbard> ;Journal of Clinical Oncology. 2004 Nov 15 Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML)
Paul T. Finger, Michael J. Pro, Susan Schneider, M. Kurli, Ilan Shapira, Kenneth S. Hu> ;American Journal of Ophthalmology. 2004 Oct 1 Alemtuzumab in B-cell chronic lymphocytic leukemia.
Ilan Shapira, Michael L. Grossbard> ;Clinical Lymphoma. 2004 Mar 1 Join now to see all Insurance Accepted Aetna Choice POS II
HIP of New York - Select PPO
Please verify your coverage with the provider's office directly when scheduling an appointment 
Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Hematology and Medical Oncology, 1994 - 1997
Loyola University Medical CenterInternship, Internal Medicine, 1991 - 1992
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1991
NY State Medical License 1997 - 2026
IL State Medical License 1994 - 1996
The Mount Sinai HospitalNew York, New York
Mount Sinai WestNew York, New York
Mount Sinai MorningsideNew York, New York
Mount Sinai Beth IsraelNew York, New York
